BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38452872)

  • 1. Umbilical Cord Blood Transplantation for Fanconi Anemia With a Special Focus on Late Complications: a Study on Behalf of Eurocord and SAAWP-EBMT.
    Rafii H; Volt F; Bierings M; Dalle JH; Ayas M; Rihani R; Faraci M; de Simone G; Sengeloev H; Passweg J; Cavazzana M; Costello R; Maertens J; Biffi A; Johansson JE; Montoro J; Guepin GR; Diaz MA; Sirvent A; Kenzey C; Rivera Franco MM; Cappelli B; Scigliuolo GM; Rocha V; Ruggeri A; Risitano A; De Latour RP; Gluckman E
    Transplant Cell Ther; 2024 May; 30(5):532.e1-532.e16. PubMed ID: 38452872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in China.
    Tong J; Xuan L; Sun Y; Huang D; Liu H; Zheng C; Zhu X; Tang B; Song K; Zhang X; Zhang L; Yao W; Lin D; Liu Q; Sun Z
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1541-1548. PubMed ID: 28499936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.
    Gluckman E; Rocha V; Ionescu I; Bierings M; Harris RE; Wagner J; Kurtzberg J; Champagne MA; Bonfim C; Bittencourt M; Darbyshire P; Fernandez MN; Locatelli F; Pasquini R;
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1073-82. PubMed ID: 17697970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
    Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
    Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
    Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
    J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia.
    Bizzetto R; Bonfim C; Rocha V; Socié G; Locatelli F; Chan K; Ramirez O; Stein J; Nabhan S; Miranda E; Passweg J; de Souza CA; Gluckman E;
    Haematologica; 2011 Jan; 96(1):134-41. PubMed ID: 21071499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience.
    Bernard F; Uppungunduri CRS; Meyer S; Cummins M; Patrick K; James B; Skinner R; Tewari S; Carpenter B; Wynn R; Veys P; Amrolia P;
    Br J Haematol; 2021 May; 193(4):804-813. PubMed ID: 33855694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of umbilical cord blood transplantation and hematopoietic stem cell transplantation from HLA-matched sibling donors in the treatment of myelodysplastic syndrome-EB or acute myeloid leukemia with myelodysplasia-related changes].
    Zhu J; Tang BL; Song KD; Zhang XH; Zhu XY; Yao W; Wan X; Liu HL; Sun ZM
    Zhonghua Xue Ye Xue Za Zhi; 2019 Apr; 40(4):294-300. PubMed ID: 31104440
    [No Abstract]   [Full Text] [Related]  

  • 10. Umbilical Cord Blood Transplantation Using Reduced-Intensity Conditioning without Antithymocyte Globulin in Adult Patients with Severe Aplastic Anemia.
    Ochi T; Onishi Y; Nasu K; Onodera K; Kobayashi M; Ichikawa S; Fujiwara T; Fukuhara N; Yamada-Fujiwara M; Harigae H
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):e55-e59. PubMed ID: 30292011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia.
    Onishi Y; Mori T; Yamazaki H; Hiramoto N; Zaimoku Y; Kanaya M; Matsue K; Onizuka M; Aotsuka N; Uchida N; Onodera K; Kanda J; Nakamae H; Yamamoto R; Kuriyama T; Kimura T; Ichinohe T; Atsuta Y;
    Transplant Cell Ther; 2023 Dec; 29(12):766.e1-766.e8. PubMed ID: 37730121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.
    Parikh SH; Mendizabal A; Benjamin CL; Komanduri KV; Antony J; Petrovic A; Hale G; Driscoll TA; Martin PL; Page KM; Flickinger K; Moffet J; Niedzwiecki D; Kurtzberg J; Szabolcs P
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):326-36. PubMed ID: 24296492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes.
    Chen YB; Wang T; Hemmer MT; Brady C; Couriel DR; Alousi A; Pidala J; Urbano-Ispizua A; Choi SW; Nishihori T; Teshima T; Inamoto Y; Wirk B; Marks DI; Abdel-Azim H; Lehmann L; Yu L; Bitan M; Cairo MS; Qayed M; Salit R; Gale RP; Martino R; Jaglowski S; Bajel A; Savani B; Frangoul H; Lewis ID; Storek J; Askar M; Kharfan-Dabaja MA; Aljurf M; Ringden O; Reshef R; Olsson RF; Hashmi S; Seo S; Spitzer TR; MacMillan ML; Lazaryan A; Spellman SR; Arora M; Cutler CS
    Bone Marrow Transplant; 2017 Mar; 52(3):400-408. PubMed ID: 27941764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloablative Unrelated Cord Blood Transplantation in Adolescents and Young Adults with Acute Leukemia.
    Hayashi H; Volt F; Sanz J; Petersen E; Dhedin N; Hough R; Milpied N; Angelucci E; Yakoub-Agha I; Michallet M; Michel G; Aljurf M; Kenzey C; Rocha V; Dalle JH; Bader P; Ruggeri A; Gluckman E;
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2438-2446. PubMed ID: 31394275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrelated cord blood transplantation vs. HLA-matched sibling transplantation for adults with B-cell acute lymphoblastic leukemia in complete remission: superior OS for patients with long-term survival.
    Sun G; Tang B; Song K; Wu Y; Tu M; Wan X; Yao W; Geng L; Qiang P; Zhu X
    Stem Cell Res Ther; 2022 Oct; 13(1):500. PubMed ID: 36210439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Conditioning Regimen Can Significantly Promote Post-Transplant Immune Reconstitution and Improve the Outcome of Umbilical Cord Blood Transplantation for Patients.
    Yu ZP; Ding JH; Sun AN; Chen BA; Ge Z; Wu DP
    Stem Cells Dev; 2019 Oct; 28(20):1376-1383. PubMed ID: 31464164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis.
    Ruggeri A; Volt F; Locatelli F; Michel G; Diaz de Heredia C; Abecasis M; Zecca M; Vora A; Yakouben K; O'Brien TA; Giardino S; Cornish J; Rocha V; Peters C; Bader P; Gluckman E; Dalle JH
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):96-102. PubMed ID: 27777140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial.
    Abraham A; Cluster A; Jacobsohn D; Delgado D; Hulbert ML; Kukadiya D; Murray L; Shenoy S
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1587-1592. PubMed ID: 28578010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The curative efficacy of unrelated umbilical cord blood stem cells transplantation in intensified myeloablative conditioned patients with acute lymphoblastic leukemia].
    Tang B; Zheng C; Liu H; Zhu X; Geng L; Wang X; Ding K; Yao W; Tong J; Song K; Zhang L; Qiang P; Zhang X; Sun Z
    Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):191-5. PubMed ID: 26926370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.